| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 52 | 291,577 | IFF, MSFT, T, DD | 13F-HR | 11/14/2024 | 000139834424020712 |
| Q2 2024 | 53 | 283,225 | MSFT, AMZN, IFF, WFC | 13F-HR | 8/14/2024 | 000139834424014601 |
| Q1 2024 | 52 | 311,166 | TSM, MSFT, WFC, AMZN | 13F-HR | 5/15/2024 | 000139834424009628 |
| Q4 2023 | 53 | 289,651 | SPG, MSFT, ASML, BA | 13F-HR | 2/14/2024 | 000139834424002894 |
| Q3 2023 | 53 | 259,748 | MSFT, BIIB, WFC, IFF | 13F-HR | 11/14/2023 | 000139834423020606 |
| Q2 2023 | 55 | 283,314 | MSFT, AMZN, TSM, ASML | 13F-HR | 8/14/2023 | 000139834423014729 |
| Q1 2023 | 52 | 264,276 | BUD, MSFT, TSM, ASML | 13F-HR | 5/15/2023 | 000139834423009680 |
| Q4 2022 | 52 | 254,510 | BUD, WFC, KHC, BA | 13F-HR | 2/14/2023 | 000139834423003161 |
| Q3 2022 | 48 | 240,889 | CVS, WFC, MSFT, BIIB | 13F-HR | 11/14/2022 | 000139834422021948 |
| Q2 2022 | 48 | 275,261 | K, T, KHC, GSK | 13F-HR | 8/15/2022 | 000139834422015547 |
| Q1 2022 | 48 | 314,991 | KHC, GSK, K, BMY | 13F-HR | 5/16/2022 | 000139834422009648 |
| Q4 2021 | 54 | 290,859 | SPG, CVS, WFC, MSFT | 13F-HR | 2/14/2022 | 000139834422002932 |
| Q3 2021 | 51 | 284,767 | WFC, SPG, BA, KHC | 13F-HR | 11/15/2021 | 000139834421021432 |
| Q2 2021 | 48 | 262,807 | WFC, AMZN, XOM, SPG | 13F-HR | 8/16/2021 | 000139834421016236 |
| Q1 2021 | 43 | 227,997 | WFC, XOM, K, KHC | 13F-HR | 5/14/2021 | 000139834421010696 |
| Q4 2020 | 46 | 185,242 | JWN, DD, MSFT, WFC | 13F-HR | 2/12/2021 | 000139834421003097 |
| Q3 2020 | 36 | 142,088 | MSFT, INTC, CMP, BIIB | 13F-HR | 11/9/2020 | 000139834420021716 |
| Q2 2020 | 38 | 137,279 | AMZN, MSFT, DD, KHC | 13F-HR | 8/4/2020 | 000139834420014959 |
| Q1 2020 | 36 | 104,413 | AMZN, BIIB, MSFT, BMY | 13F-HR | 4/29/2020 | 000139834420008780 |
| Q4 2019 | 50 | 141,107 | JWN, MSFT, BMY, BIIB | 13F-HR | 2/14/2020 | 000139834420003500 |
| Q4 2013 | 38 | 66,891 | RTN, AXP, BAC, AAPL | 13F-HR | 2/7/2014 | 000139834414000674 |